Literature DB >> 27366275

Medullomyoblastoma: A rare case in an unusual location in an atypical age group.

Sumit Bansal1, Sachin A Borkar1, Ashish Suri1, Mehar C Sharma2, Ashok K Mahapatra1.   

Abstract

Medullomyoblastoma is a variant of medulloblastoma with an aggressive course. It is typically seen in children less than 10 years of age and usually arises from the cerebellar vermis. Authors report an unusual case of medullomyoblastoma arising from the right middle cerebellar peduncle in an adult patient and pertinent literature is reviewed regarding this uncommon entity.

Entities:  

Keywords:  cerebellar peduncle; medulloblastoma; medullomyoblastoma; posterior fossa tumors

Year:  2016        PMID: 27366275      PMCID: PMC4849317          DOI: 10.4103/1793-5482.144167

Source DB:  PubMed          Journal:  Asian J Neurosurg


Introduction

Medullomyoblastoma (MMB) was first described by Marinesco and Goldstein in 1933,[1] is a unique variant of medulloblastoma with more aggressive nature.[2] Typical affected age group is less than 10 years of age with occasional case reports in adults. Majority of patients present with symptoms of increased intracranial pressure.[2] Tumor is classified as WHO grade IV and is defined histopathologically as a combination of primitive neuroectodermal and myoblastic elements.[3] Authors report a rare case of medullomyoblastoma arising from the middle cerebellar peduncle in an adult patient.

Case Report

Clinical history

A 32-years-old male presented with two months history of gait ataxia. On examination right hemiparesis (4/5, MRC grading), left VII nerve paresis (H and B grade III) and right cerebellar signs were present. Rest of the neurological examination was normal.

Imaging

Head CT revealed a heterogeneous solid cystic mass arising from the brainstem and extending to right cerebello-pontine angle [Figure 1a]. MRI revealed a right middle cerebellar peduncle lesion (33 × 30 × 28 mm) extending to right cerebello-pontine angle with necrotic and hemorrhagic areas. The lesion was isointense on T1W, hyper intense on T2W with inhomogeneous postcontrast enhancement [Figure 1b–d]. There was mild mass effect over fourth ventricle, but no upstream hydrocephalus.
Figure 1

Head CT scan showing hyperdense lesion in right cerebello-pontine angle (a); T1-W axial postcontrast MRI (b); T2-W axial MRI (c) and T2-W coronal MRI (d) Images showing contrast enhancing mass in right middle cerebellar peduncle with cerebello pontine angle extension

Head CT scan showing hyperdense lesion in right cerebello-pontine angle (a); T1-W axial postcontrast MRI (b); T2-W axial MRI (c) and T2-W coronal MRI (d) Images showing contrast enhancing mass in right middle cerebellar peduncle with cerebello pontine angle extension

Operative procedure

Right retro-sigmoid suboccipital craniotomy and near total excision of tumor was done. Intraoperatively, tumor was soft, greyish, highly vascular arising from the right middle cerebellar peduncle, infiltrating surrounding neurovascular structures, without any plane of cleavage.

Postoperative course

Patient was electively ventilated for 48 hours. Postoperative course was uneventful except for mild impairment of gag reflex, for which nasogastric feeding was started. Patient was discharged on 7th postoperative day.

Histopathological examination

The tumor tissue was fixed in neutral-buffered formalin and was routinely processed and paraffin embedded. Five-micrometer sections were cut for routine Hematoxylin and eosin staining and for immunohistochemistry. Microscopic examination showed a malignant tumor arranged in sheets comprising of round to oval to spindle cells with scant amount of cytoplasm and vesicular nuclei with prominent nucleoli. Mitoses were frequent [Figure 2a]. Some of the cells had more eosinophilic cytoplasm. The tumor cells showed diffuse immunopositivity for synaptophysin, chromogranin and focal immunopositivity for desmin and myogenin [Figure 2b–d]. MIB-1 labeling index was 6%. The tumor cells were immunonegative for p53, GFAP, epithelial membrane antigen (EMA), pancytokeratin (CK) and TTF-1.
Figure 2

Photomicrographs showing sheets of oval to spindle-shaped cells with scant to moderate amount of cytoplasm, vesicular nuclei with prominent nucleoli and frequent mitoses (a, H and E, ×400). Tumor cells are diffusely immunopositive for synaptophysin; (b) and focally for desmin and myogenin (c and d, ×400 each)

Photomicrographs showing sheets of oval to spindle-shaped cells with scant to moderate amount of cytoplasm, vesicular nuclei with prominent nucleoli and frequent mitoses (a, H and E, ×400). Tumor cells are diffusely immunopositive for synaptophysin; (b) and focally for desmin and myogenin (c and d, ×400 each) Based on above morphological and immunohistochemical features the possibility of medullomyoblastoma was considered.

Follow-up

At last follow-up, his lower cranial nerve function had improved and he was able to take food orally. MRI done 6 weeks after surgery showed no evidence of residual/recurrent tumor [Figure 3]. Patient is now undergoing radiotherapy.
Figure 3

Postcontrast T1-W axial MRI image showing complete excision of tumor in follow-up

Postcontrast T1-W axial MRI image showing complete excision of tumor in follow-up

Discussion

Medullomyoblastoma is a unique variant of medulloblastoma with more aggressive nature.[12] As per the authors’ literature review, of the patients previously described in the literature, approximately 90% were less than 10 years of age. To the best of authors’ knowledge, only five cases of adult medullomyoblastoma have been described in literature till date[24567] [Table 1]. Usual location is in the vermis and less often in the cerebellar hemispheres.[8]
Table 1

Summary of reported cases of adult medullomyoblastoma in literature

Summary of reported cases of adult medullomyoblastoma in literature MMB is considered to be a variant of medulloblastoma; however, the cell of origin of the myogenic component is controversial.[8] Ingraham and Bailey[9] and Misugi et al.[10] postulated it to be a variant of malignant teratoma consisting of a neuroectodermal and mesenchymal rhabdomyosarcomatous component. Banerjee and Kak[11] favored this hypothesis as they observed an epithelial component resembling medulloepithelioma in MMB. Chowdhary et al.[12] reported three cases of MMB with distinct teratomatous areas supporting the theory of a teratomatous origin. Russell and Rubinstein[13] suggested that MMB is derived from the primitive germinal cells located in the midline of the posterior lip of the fourth ventricle in early fetal life and hence these tumors are preferentially located in the midline. Mahapatra et al.[5] demonstrated the presence of derivatives of all the three germ layers in MMB supporting the possibility of a teratomatous origin. Lewis et al.[14] and Willis[15] suggested that the myoblastic component of MMB originates from the highly plastic embryonic pleuripotent mesenchymal cells derived from the neural crest surrounding the blood vessels in the brain and meninges. This was supported by Kartha et al.[16] who reported occasional striated muscle in the leptomeninges of the ventral pons in stillborn preterm babies. Marinesco and Goldstein[1] suggested that the striated muscles in MMB are derived from metaplastic vascular smooth muscle cells. Walter et al.[17] postulated that the myoblast originates from neoplastic transformation of the endothelial lining of the capillaries, which are mesodermal in origin. This is supported by the finding that muscle fibres in MMB are preferentially situated around the blood vessels. Furthermore, mitotic figures are seen in these endothelial cells. Lennon et al.[18] postulated that primitive neuroepithelial cells can differentiate into rhabdomyoblastic or melanocytic lines. Lantos et al.[8] reported a hamartomatous component in MMB, consistent with the theory that MMB may derive from dysplastic elements of the adjacent cerebellum. Medullomyoblastoma is a rare cerebellar tumor[11121920] with histological characteristics of medulloblastoma within which smooth and striated muscle fibers are found. The muscle elements usually present a malignant appearance. Overall, medullomyoblastoma is rapidly progressive, seen in young children with clinical symptoms ranging from a few weeks to months.[6] The recommended treatment includes radical surgery and craniospinal irradiation.[12131420] However, the survival period is very short despite surgery and radiation and has ranged from 4 days to 1 year.[6] Nevertheless, radiation does seem to prolong the period of survival.[21] Jaiswal et al.[21] reported a case of MMB with long survival after gross total resection along with craniospinal radiation and chemotherapy.

Conclusions

Medullomyoblastoma, an aggressive variant of medulloblastoma, usually seen in children less than 10 years of age, presenting in an adult is extremely rare. Histologically the tumors have a combination of different components. Despite multimodality treatment, the overall outcome is poor.
  15 in total

1.  A CASE OF MEDULLOMYOBLASTOMA.

Authors:  P J BOFIN; E EBELS
Journal:  Acta Neuropathol       Date:  1963-02-11       Impact factor: 17.088

2.  Unusually long survival in a case of medullomyoblastoma.

Authors:  Awadhesh Kumar Jaiswal; Sushila Jaiswal; Ashok Kumar Mahapatra; Mehar Chand Sharma
Journal:  J Clin Neurosci       Date:  2005-11       Impact factor: 1.961

3.  Medulloblastoma with striated muscle fibers. Case report.

Authors:  A J Lewis
Journal:  J Neurosurg       Date:  1973-05       Impact factor: 5.115

4.  Teratoid tumour of the cerebellum.

Authors:  A K Banerjee; V K Kak
Journal:  J Pathol       Date:  1973-12       Impact factor: 7.996

5.  Medullomyoblastoma in an adult.

Authors:  C Rao; M E Friedlander; E Klein; A P Anzil; J H Sher
Journal:  Cancer       Date:  1990-01-01       Impact factor: 6.860

6.  Ultrastructural study of medullomyoblastoma.

Authors:  G F Walter; J M Brucher
Journal:  Acta Neuropathol       Date:  1979-12       Impact factor: 17.088

7.  Medullomyoblastoma. A rare cerebellar tumour in children.

Authors:  A K Mahapatra; A K Sinha; M C Sharma
Journal:  Childs Nerv Syst       Date:  1998-07       Impact factor: 1.475

8.  Medullomyoblastoma. A teratoma.

Authors:  C Chowdhury; S Roy; A K Mahapatra; R Bhatia
Journal:  Cancer       Date:  1985-04-01       Impact factor: 6.860

9.  Cystic teratomas and teratoid tumors of the central nervous system in infancy and childhood.

Authors:  F D INGRAHAM; O T BAILEY
Journal:  J Neurosurg       Date:  1946-11       Impact factor: 5.115

10.  The role of immunohistochemistry in medullomyoblastoma--a case series highlighting divergent differentiation.

Authors:  Man Updesh S Sachdeva; Mahesha Vankalakunti; Aruna Rangan; Bishan D Radotra; Rajesh Chhabra; Rakesh K Vasishta
Journal:  Diagn Pathol       Date:  2008-04-25       Impact factor: 2.644

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.